FR1512M - New drug in particular for the treatment of arterial hypertension. - Google Patents

New drug in particular for the treatment of arterial hypertension.

Info

Publication number
FR1512M
FR1512M FR873701A FR873701A FR1512M FR 1512 M FR1512 M FR 1512M FR 873701 A FR873701 A FR 873701A FR 873701 A FR873701 A FR 873701A FR 1512 M FR1512 M FR 1512M
Authority
FR
France
Prior art keywords
treatment
new drug
arterial hypertension
arterial
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR873701A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR873701A priority Critical patent/FR1512M/en
Application granted granted Critical
Publication of FR1512M publication Critical patent/FR1512M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D459/00—Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR873701A 1961-06-20 1961-09-20 New drug in particular for the treatment of arterial hypertension. Active FR1512M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR873701A FR1512M (en) 1961-06-20 1961-09-20 New drug in particular for the treatment of arterial hypertension.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR865476A FR1369322A (en) 1961-06-20 1961-06-20 New Yohimbane Derivatives and Preparation Process
FR873701A FR1512M (en) 1961-06-20 1961-09-20 New drug in particular for the treatment of arterial hypertension.

Publications (1)

Publication Number Publication Date
FR1512M true FR1512M (en) 1962-10-01

Family

ID=8757627

Family Applications (2)

Application Number Title Priority Date Filing Date
FR865476A Expired FR1369322A (en) 1961-06-20 1961-06-20 New Yohimbane Derivatives and Preparation Process
FR873701A Active FR1512M (en) 1961-06-20 1961-09-20 New drug in particular for the treatment of arterial hypertension.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR865476A Expired FR1369322A (en) 1961-06-20 1961-06-20 New Yohimbane Derivatives and Preparation Process

Country Status (1)

Country Link
FR (2) FR1369322A (en)

Also Published As

Publication number Publication date
FR1369322A (en) 1964-08-14

Similar Documents

Publication Publication Date Title
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.
FR1512M (en) New drug in particular for the treatment of arterial hypertension.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR31M (en) New drug in particular for the treatment of arterial hypertension.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1387M (en) New drug in particular for the treatment of acute or chronic arterial hypertension.
FR1186M (en) New drug in particular for the treatment of acute or chronic arterial hypertension.
FR1689M (en) New drug in particular for the treatment of acute or chronic arterial hypertension.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
FR3419M (en) New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
FR2323M (en) New drug, in particular for the treatment of follicle-stimulating hyperactivity.
FR3641M (en) New drug in particular for the treatment of states of adynamia.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR1596M (en) Drug for the treatment of alcoholism.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.